Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 42.48
+0.19 (0.45%)
Jun 27, 2025, 2:45 PM CST
SHE:002653 Revenue
Haisco Pharmaceutical Group had revenue of 892.01M CNY in the quarter ending March 31, 2025, with 18.60% growth. This brings the company's revenue in the last twelve months to 3.86B, up 10.84% year-over-year. In the year 2024, Haisco Pharmaceutical Group had annual revenue of 3.72B with 10.92% growth.
Revenue (ttm)
3.86B
Revenue Growth
+10.84%
P/S Ratio
12.22
Revenue / Employee
723.48K
Employees
5,337
Market Cap
47.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
| Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
| Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
| Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
| Dec 31, 2020 | 3.33B | -607.74M | -15.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |